Clinical Trials Logo

Hypochondriasis clinical trials

View clinical trials related to Hypochondriasis.

Filter by:

NCT ID: NCT05942391 Not yet recruiting - Anxiety Disorders Clinical Trials

Brief-intensive CBT Versus Once-weekly CBT in Anxiety-related Disorders

KOMMA
Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare brief-intensive cognitive-behaviour therapy (CBT) with regular weekly CBT in people with anxiety-related disorders. The main question to answer is: will brief-intensive CBT improve functioning (work, family, social) more and faster than does regular weekly CBT? Participants will be asked to follow CBT treatment (20 sessions of 45 minutes in both conditions), and participate in 7 measurements with a total duration of 5 hours over 1 year. Researchers will compare: - Brief-intensive CBT: 16 sessions in 2 weeks + 4 follow-up sessions within 3 months - Regular CBT with 20 weekly sessions in 6 months

NCT ID: NCT04921280 Completed - Clinical trials for Somatic Symptom Disorder

Effectiveness of ICBT for Severe Health Anxiety in Clinical Psychiatry.

Start date: April 1, 2018
Phase:
Study type: Observational

The aim of this study is to evaluate the clinical effectiveness of internet-based cognitive therapy for severe health anxiety within regular psychiatric care. A longitudinal cohort study will be conducted investigating 400 patients who have received ICBT for severe health anxiety between 2018-2020 in an outpatient psychiatric clinic providing Internet-based treatment. The primary outcome measure will be the Short Health Anxiety Inventory, SHAI, and a within-group design with repeated measures will be used for primary analysis. It is hypothesized that ICBT will be associated with a significant reduction in health anxiety as measured with SHAI, both after treatment and at six-month follow-up.

NCT ID: NCT04900064 Recruiting - Depression Clinical Trials

Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial

KAIROS
Start date: June 14, 2021
Phase: N/A
Study type: Interventional

In this multicenter study, the investigators want to find out if an addition of an diagnostic assessment and possibility of treatment with guided self-help CBT can increase the treatment effects of PCBH on patient functioning and symptoms, compared to standard PCBH which uses contextual assessment and brief interventions. In addition to this, the study will investigate the overall effect of PCBH on both patient and organisation level outcomes.

NCT ID: NCT03024593 Not yet recruiting - Hypochondriasis Clinical Trials

An Examination of the Effects of Health-related Internet Use in Individuals With Pathological Health Anxiety

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of the current study is to examine the effects of health-related internet use on affect, health anxiety and symptom severity in individuals with pathological levels of health anxiety. The present randomized controlled study compares an online medical searching condition with a waiting (i.e. non-searching) condition to manipulate the attentional focus. After an induction of health anxiety using the Autobiographical Emotional Memory Task the participants in the searching condition go online and search for subjectively relevant health information (external focus of attention). Individuals in the waiting (i.e. non-searching) condition are requested to do nothing and not to distract themselves (internal focus of attention).

NCT ID: NCT02735434 Completed - Hypochondriasis Clinical Trials

Internet-delivered Acceptance and Commitment Therapy for Patients With Health Anxiety

Start date: April 2016
Phase: N/A
Study type: Interventional

Health anxiety is a prevalent, disabling disorder associated with extensive health care expenditures. The lack of easily accessible, evidence-based psychological treatment combined with delayed diagnostic recognition constitute barriers to receiving treatment. Aim 1. To develop an internet-delivered treatment program, based on 'Acceptance and Commitment Therapy' (ACT), for patients with health anxiety. 2. To test the feasibility and effectiveness of the treatment programme in a randomized, controlled trial, comparing the treatment with an active control condition. Methods 150 patients aged 18 years and older can self-refer through a web-page to apply for participation. Before inclusion patients will undergo a video-diagnostic interview. Patients are randomly assigned to 12 weeks of either, 1) active treatment: consisting of internet-based ACT (iACT) with 7 therapist-guided modules of self-help text, exercises, patient videos and audio-files, or 2) active control condition: consisting of an internet-based discussion forum (iFORUM) with 7 topics of discussion. All patients will complete self-report questionnaires at baseline, before randomization, at 4 and 8 weeks into treatment, after end of treatment, and at 6-month follow-up.

NCT ID: NCT02404116 Completed - Hypochondriasis Clinical Trials

Metacognitive Therapy for Health Anxiety

Start date: March 2015
Phase: N/A
Study type: Interventional

The study involves a comparing a new psychological treatment- Metacognitive Therapy (MCT) which has shown promising results in the treatment of health anxiety to no treatment at all- a waiting list.

NCT ID: NCT02131883 Completed - Clinical trials for Personality Disorders

Outcome of Cognitive Behavioral Therapy for Patients With Severe Health Anxiety Treated in Group Only. A RCT.

CHAG
Start date: February 2014
Phase: N/A
Study type: Interventional

Background: The prevalence of severe health anxiety is reported to be 1-2% in Western communities. This functional disorder is difficult for medical doctors to treat, the course of the disorder is often chronic, and that is costly for the social and health care systems as well as for the patients. A Cochrane metaanalysis from 2009 finds evidence for effectiveness of individual cognitive behavior therapy (CBT) for patients with hypochondriasis. But no randomised controlled trials (RCT) of the effectiveness of classical CBT delivered only in groups for patients with severe health anxiety (hypochondriasis/illness anxiety disorder) has yet been conducted. Aims: 1) to examine the effectiveness of group-CBT for patients with severe health anxiety compared to a wait-list group receiving usual care, 2) to perform a categorical and dimensional assessment of personality, 3) to examine predictors of outcome especially comorbid personality disorders, 4) to examine the relation between personality, illness perception and treatment outcome, 5) to compare the cost-effectiveness of these two treatments, 6) at a 2 years follow up to examine the course and long-term effectiveness of group-CBT for patients with severe health anxiety and some also followed by psychological treatment for comorbid personality disorders. Main hypothesis: Patients with severe HA who have received group CBT will at 6-month follow-up compared to a wait-list group receiving usual care show a significantly reduction in health anxiety. Methods: 84 patients referred from medical doctors during 2014-15 to the Clinic of Liaison Psychiatry in Koege, Region Zealand, Denmark, will be included and block randomised per 14 patients to either weekly group-CBT with 7 patients and 2 therapists for 3 hours a week in 12 weeks or wait-list with usual care for 9 months. Inclusion: Severe health anxiety (dominant mental disorder), score on WI-7>21,4, age 18-65 years, Danish speaking, informed consent. Exclusion: Another severe treatment demanding mental disorder, risk of suicide or psychosis, a serious somatic disease, pregnancy, dependency of drugs, alcohol or medication. Diagnostic assessment: The patients are included using research criteria for severe health anxiety (for ICD-11) and semi-structured interviews developed for DSM-IV, SCAN (general psychopathology) and SCID-II (personality disorders). Criteria for hypochondriasis from ICD-10 and illness anxiety disorder/somatic symptom disorder from DSM-5 are used for subcategorising. Dimensions and traits of personality are assessed by the questionnaire PID-5 included in DSM-5, section III. Outcome measures: The primary outcome measure is the questionnaire for health anxiety, Whiteley Index 7 (WI-7), with a cut-off for remission on 21,4 or a blinded diagnostic assessment of no severe health anxiety present 6 months after end of treatment. The secondary outcome measures are questionnaires for health anxiety (HAI), general psychopathology (SCL-90-R), level of personality disorders (PID-5), level of functioning (SF-36), quality of life (WHO-5, EQ-5D), Illness perception (IPQ), alcohol consumption (CAGE) and register data for number of sick days and use of social and health care and a blinded global assessment of functioning (F-GAF). Time frame: Data wil be analysed, and results wil be disseminated from 2016.

NCT ID: NCT01673035 Completed - Hypochondriasis Clinical Trials

Internet Treatment for Health Anxiety

HA-X
Start date: September 2012
Phase: N/A
Study type: Interventional

Background Severe health anxiety, hypochondriasis according to DSM-IV, is common and associated with functional disability. Cognitive behavior therapy (CBT) and behavioral stress management (BSM) have been showed to be effective in the treatment of severe health anxiety. The mechanisms of the treatments are however poorly understood. In addition, effective psychological treatments are accessible to only a few. One prior RCT has shown that internet-based CBT could be effective in comparison to waiting list controls. More studies on internet-based CBT is essential to establish evidence. In addition, few studies with sufficient power have investigated the effect of CBT in comparison to other active treatments. Aim of the study The aim of the present RCT is to compare internet-based CBT (n=110) to behavioral stress management (n=110) for adult participants with severe health anxiety. BSM is considered a comparison treatment for two reasons: it has been shown to be effective and it lacks exposure and response prevention, which is suggested to be an important mechanism in CBT. Participants in both treatments are expected to be significantly improved on measures of health anxiety. Participants receiving CBT are expected to be significantly more improved compared to participants receiving BSM.

NCT ID: NCT01158430 Completed - Hypochondriasis Clinical Trials

Acceptance and Commitment Group Therapy (ACT) for Patients With Health Anxiety

ACT
Start date: March 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of Acceptance and Commitment Therapy (ACT) in groups on functional level, emotional problems, and use of health care in patients with severe health anxiety in a randomized, controlled design.

NCT ID: NCT01119469 Completed - Clinical trials for Somatoform Disorders

Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis

Start date: June 2010
Phase: Phase 3
Study type: Interventional

This study will compare the efficacy of cognitive therapy and exposure therapy for treating hypochondriasis.